moxifloxacin has been researched along with Infections in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arrieta, AC; Bradley, JS; James, LP; Lettieri, J; Stass, H; Sullivan, JE; Vanevski, KM; Willmann, S | 1 |
| Dadashzadeh, S; Haeri, A; Mahboubi, A; Mortazavi, A; Sohrabi, S | 1 |
| Cachovan, G; Dogan-Onur, O; Nergiz, I; Oral, O; Platzer, U; Siefert, HM; Sobottka, I; Thuss, U | 1 |
1 trial(s) available for moxifloxacin and Infections
| Article | Year |
|---|---|
Pharmacokinetics, Safety, and Tolerability of Single-Dose Intravenous Moxifloxacin in Pediatric Patients: Dose Optimization in a Phase 1 Study.
Topics: Administration, Intravenous; Adolescent; Adult; Anti-Bacterial Agents; Area Under Curve; Child; Child, Preschool; Cohort Studies; Dose-Response Relationship, Drug; Female; Humans; Infant; Infections; Male; Moxifloxacin | 2019 |
2 other study(ies) available for moxifloxacin and Infections
| Article | Year |
|---|---|
Chitosan gel-embedded moxifloxacin niosomes: An efficient antimicrobial hybrid system for burn infection.
Topics: Anti-Infective Agents; Burns; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Drug Delivery Systems; Drug Liberation; Fluoroquinolones; Gels; Infections; Microbial Sensitivity Tests; Moxifloxacin; Particle Size; Spectroscopy, Fourier Transform Infrared; Staphylococcus aureus; Viscosity | 2016 |
Penetration of moxifloxacin into rat mandibular bone and soft tissue.
Topics: Alveolar Process; Animals; Anti-Infective Agents; Aza Compounds; Fluoroquinolones; Infections; Male; Mandible; Masseter Muscle; Moxifloxacin; Periodontal Diseases; Quinolines; Random Allocation; Rats; Rats, Wistar; Tooth Diseases | 2009 |